View More Recent Stories
-
BofA Securities Downgrades Edwards Lifesciences (EW) to Neutral
-
Edwards Lifesciences (EW) PT Lowered to $73 at Piper Sandler
-
TD Cowen Downgrades Edwards Lifesciences (EW) to Hold
-
Edwards Lifesciences (EW) PT Lowered to $85 at Mizuho
-
Edwards Lifesciences (EW) PT Lowered to $85 at RBC Capital
-
Edwards Lifesciences (EW) PT Lowered to $77 at Canaccord Genuity
-
Edwards Lifesciences (EW) PT Lowered to $76 at Evercore ISI
-
Truist Securities Downgrades Edwards Lifesciences (EW) to Hold
-
JPMorgan Downgrades Edwards Lifesciences (EW) to Neutral
-
Edwards Lifesciences (EW) Tops Q2 EPS by 1c; offers guidance
-
After-hours movers: Chipotle Mexican Grill, Ford, IBM, Edwards Lifesciences, and more
-
Edwards Lifesciences (EW) Reports Acquisitions of JenaValve and Endotronix
-
TD Cowen Reiterates Buy Rating on Edwards Lifesciences (EW)
-
TD Cowen Reiterates Buy Rating on Edwards Lifesciences (EW)
-
Edwards Lifesciences (EW) PT Raised to $110 at Truist Securities
-
BTIG Reiterates Neutral Rating on Edwards Lifesciences (EW)
-
Edwards Lifesciences (EW) to Acquire Innovalve
-
MedTech stocks: Q2 earnings season preview
-
Edwards Lifesciences (EW) said to mull takeover bid for AtriCure (ATRC) - source

